March 13, 2017 – Ringwood, NJ – The Pharma & Biopharma Outsourcing Association (PBOA) applauds the nomination of Dr. Scott Gottlieb to lead the Food and Drug Administration. PBOA President Gil Roth remarked, “Dr. Gottlieb brings a wealth of knowledge and perspective about the healthcare system, the structure and processes of the FDA, and the value of timely approval of new medicines and therapeutics. We support his prompt confirmation by the U.S. Senate and look forward to working with him as PBOA members advance the manufacturing technologies and drug delivery solutions that will bring safe and cost-effective medicines to patients.”
About the PBOA
Founded in 2014, the Pharma & Biopharma Outsourcing Association (PBOA) is a nonprofit trade association dedicated to advancing the regulatory, legislative and general business interests of Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs). PBOA members provide the services that help the pharma and biopharma industry develop and manufacture drugs, biologics, vaccines, and other treatments safely and cost effectively. For more information about the PBOA, its members, and its mission, please visit www.pharma-bio.org. Follow us on Twitter at @PBOAssoc.
For more information: